Unknown PHASE3 INTERVENTIONAL 2-arm NCT00659451

Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular

Effects Of Losartan On Myocardial Structure And Function And On Epicardial Fat Deposition In Diabetic Hypertensive Patients With Left Ventricular: Qualitative And Quantitative Alteration

Sponsor: University of Pavia

Conditions Diabetes Mellitus Essential Hypertension

Interventions Amlodipine Losartan

Updated 4 times since 2017 Last updated: Apr 14, 2008 Started: Apr 30, 2008 Primary completion: Apr 30, 2008 Completion: Apr 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Diabetes Mellitus and Essential Hypertension and is currently ongoing. University of Pavia leads this study, which shows 4 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE3

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pavia

Data source: University of Pavia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pavia, Italy